The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 24, 2018

Filed:

Aug. 20, 2013
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Steven F. Dowdy, La Jolla, CA (US);

Bryan R. Meade, San Diego, CA (US);

Khirud Gogoi, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/713 (2006.01); A61K 31/7125 (2006.01); C07H 21/00 (2006.01); C07H 21/02 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); A61K 31/7125 (2013.01); A61K 47/645 (2017.08); C07H 21/00 (2013.01); C07H 21/02 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); C12N 2310/351 (2013.01); C12N 2320/32 (2013.01); C12N 2810/40 (2013.01); Y02P 20/55 (2015.11);
Abstract

The disclosure provides methods and compositions for delivering polynucleotides into cells. The disclosure provides transiently protected polynucleotides comprising an anionic charge-neutralizing moiety/group, which may also confer additional functionality. These compounds can enter the cytosol of cells by endocytic or macropinocytic mechanisms. The transient protecting group is bioreversible, i.e., once inside a cell, it is designed to be removed by enzymatic activity or by passive intracellular methods (e.g., changes in pH or reductive environment).


Find Patent Forward Citations

Loading…